PROSTATE CANCER MORTALITY AND METASTASIS UNDER DIFFERENT BIOPSY FREQUENCIES IN NORTH AMERICAN ACTIVE SURVEILLANCE COHORTS

被引：0
|
作者：
Lange, Jane [1 ]
Etzioni, Ruth [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
MEDICAL DECISION MAKING | 2020年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
2F-5
引用
收藏
页码：E302 / E303
页数：2
相关论文
共 50 条
  • [31] Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients
    Shankar, Prasad R.
    Maturen, Katherine E.
    George, Arvin K.
    Borza, Tudor
    Ellimoottil, Chandy
    Montgomery, Jeffrey S.
    Wei, John T.
    Denton, Brian T.
    Davenport, Matthew S.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2019, 16 (10) : 1385 - 1392
  • [32] Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study
    Moschini, Marco
    Fossati, Nicola
    Sood, Akshay
    Lee, Justin K.
    Sammon, Jesse
    Sun, Maxine
    Pucheril, Dan
    Dalela, Deepansh
    Montorsi, Francesco
    Karnes, R. Jeffrey
    Briganti, Alberto
    Quoc-Dien Trinh
    Menon, Mani
    Abdollah, Firas
    EUROPEAN UROLOGY FOCUS, 2018, 4 (01): : 68 - 74
  • [33] Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance
    Al Otaibi, Mohammed
    Ross, Philip
    Fahmy, Nader
    Jeyaganth, Suganthiny
    Trottier, Helen
    Sircar, Kanishka
    Begin, Louis R.
    Souhami, Luis
    Kassouf, Wassim
    Aprikian, Armen
    Tanguay, Simon
    CANCER, 2008, 113 (02) : 286 - 292
  • [34] Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
    Andreas, Darian
    Tosoian, Jeffrey J.
    Landis, Patricia
    Wolf, Sacha
    Glavaris, Stephanie
    Lotan, Tamara L.
    Schaeffer, Edward M.
    Sokoll, Lori J.
    Ross, Ashley E.
    UROLOGY CASE REPORTS, 2016, 7 : 64 - 66
  • [35] Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy
    Borkowetz, Angelika
    Renner, Theresa
    Platzek, Ivan
    Toma, Marieta
    Herout, Roman
    Baunacke, Martin
    Groeben, Christer
    Huber, Johannes
    Laniado, Michael
    Baretton, Gustavo B.
    Froehner, Michael
    Zastrow, Stefan
    Wirth, Manfred P.
    UROLOGIA INTERNATIONALIS, 2018, 100 (02) : 155 - 163
  • [36] MRI improves active surveillance of prostate cancer however biopsy is still crucial
    Thompson, James E.
    Stricker, Phillip D.
    BJU INTERNATIONAL, 2018, 122 (02) : E1 - E2
  • [37] Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
    Jonathan H. Wang
    Pablo Sierra
    Kyle A. Richards
    E. Jason Abel
    Glen O. Allen
    Tracy M. Downs
    David F. Jarrard
    BMC Urology, 19
  • [38] Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance
    Tosoian, Jeffrey J.
    Mamawala, Mufaddal
    Patel, Hiten D.
    Alam, Ridwan
    Epstein, Jonathan I.
    Ross, Ashley E.
    Carter, Ballentine
    JOURNAL OF UROLOGY, 2018, 199 (04): : 954 - 959
  • [39] NEGATIVE MRI CANNOT BE USED TO AVOID BIOPSY IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Chesnut, Gregory
    Vertosick, Emily
    Benfante, Nicole
    Sjoberg, Daniel
    Eastham, James
    Fainberg, Jonathan
    Laudone, Vincent
    Lee, Taehyoung
    Scardino, Peter
    Touijer, Karim
    Vickers, Andrew
    Ehdaie, Behfar
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1013 - E1013
  • [40] OUTCOMES OF SCHEDULED VERSUS FOR CAUSE BIOPSY REGIMENS FOR PROSTATE CANCER ACTIVE SURVEILLANCE
    Altartir, Tareq
    Murekeyisoni, Christine
    Mehedint, Diana
    Kauffman, Eric
    Mohler, James
    Attwood, Kristopher
    JOURNAL OF UROLOGY, 2014, 191 (04): : E721 - E721
12345